Ado-trastuzumab emtansine and Metformin and repaglinide
Determining the interaction of Ado-trastuzumab emtansine and Metformin and repaglinide and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ado-trastuzumab emtansine
Brand name: Kadcyla
Synonyms: Ado-Trastuzumab Emtansine
Generic Name: metformin / repaglinide
Brand name: PrandiMet
Synonyms: Repaglinide and Metformin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ado-trastuzumab emtansine-Metformin and saxagliptin
- Ado-trastuzumab emtansine-Metformin and sitagliptin
- Ado-trastuzumab emtansine-Metformin Extended-Release Tablets
- Ado-trastuzumab emtansine-Metformin Hydrochloride
- Ado-trastuzumab emtansine-Metformin Oral Solution
- Ado-trastuzumab emtansine-Metformin Tablets
- Metformin and repaglinide-Ado-trastuzumab emtansine Intravenous
- Metformin and repaglinide-Adox Pak 2/100
- Metformin and repaglinide-Adoxa
- Metformin and repaglinide-Adoxa CK
- Metformin and repaglinide-Adoxa Pak
- Metformin and repaglinide-Adoxa Pak 1/100